Optolane Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Later Stage VC
- Investors
-
14
Optolane General Information
Description
Developer of a diagnostic device intended to provide molecular and immunoassay POCT alternatives. The company's semiconductor-integrated In-Vitro Diagnostic device specializes in real-time PCR and Digital PCR through the integration of optical and thermal control systems, enabling individuals to get diseases diagnosed and improve their quality of life.
Contact Information
Website
www.optolane.comCorporate Office
- Number A-301, 3rd Floor, 357, Guseong-ro
- Giheung-gu
- Yongin, Gyeonggi
- South Korea
Corporate Office
- Number A-301, 3rd Floor, 357, Guseong-ro
- Giheung-gu
- Yongin, Gyeonggi
- South Korea
Optolane Timeline
Optolane Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 01-Jan-2026 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 25-Jul-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 01-Jan-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 26-May-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 01-Dec-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B1) | 01-Aug-2018 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 01-Aug-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Jul-2017 | $14.1M | $19.6M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-Oct-2015 | $5.47M | $5.47M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Optolane Patents
Optolane Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025187967-A1 | Method for manufacturing backplane for micro-display | Pending | 05-Mar-2024 | ||
| WO-2025187967-A8 | Method for manufacturing backplane for micro-display | Pending | 05-Mar-2024 | ||
| WO-2025155157-A1 | Melting curve analysis method | Inactive | 17-Jan-2024 | ||
| WO-2026079933-A1 | Composition for cancer diagnosis for digital pcr and information providing method for cancer diagnosis | Pending | 13-Oct-2023 | ||
| EP-4653550-A1 | Method and cartridge for diagnosing foot-and-mouth disease virus using semiconductor biosensor-based polymerase chain reaction technique | Pending | 19-Jan-2023 | C12Q1/701 |
Optolane Signals
Optolane Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| East Gate Partners | Venture Capital | Minority | ||
| Trust Venture Investment | Venture Capital | Minority | ||
| Intops Investment | Venture Capital | Minority | ||
| iM Investment Partners | Corporate Venture Capital | Minority | ||
| Genomictree | Corporation | Minority |
Optolane FAQs
-
When was Optolane founded?
Optolane was founded in 2012.
-
Where is Optolane headquartered?
Optolane is headquartered in Yongin, South Korea.
-
What is the size of Optolane?
Optolane has 45 total employees.
-
What industry is Optolane in?
Optolane’s primary industry is Diagnostic Equipment.
-
Is Optolane a private or public company?
Optolane is a Private company.
-
What is Optolane’s current revenue?
The current revenue for Optolane is .
-
How much funding has Optolane raised over time?
Optolane has raised $75.4M.
-
Who are Optolane’s investors?
East Gate Partners, Trust Venture Investment, Intops Investment, iM Investment Partners, and Genomictree are 5 of 14 investors who have invested in Optolane.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process